Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2015

Mar 10, 2015

30198_dirs_2015-03-10_7d916749-3e2b-4342-a4ff-7c157efd4bd2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2015-03-08

Reporting Person: GREGG TERRANCE H (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-03-08 Common Stock A 35000.0 $0.0010 Acquired 430626 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 11461 Indirect
Common Stock 566389 Indirect

Footnotes

F1: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and subject to vesting in one annual installment from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. common stock.

F2: Included in this number are 222,892 unvested restricted stock units, 35,000 of which were granted on March 8, 2015 and will vest on March 8, 2016, 121,876 unvested restricted stock units granted on March 8, 2014, 5,078 of which shall vest each month through March 8, 2017, and 66,016 unvested restricted stock units granted on March 11, 2013, 5,078 of which shall vest each month through March 11, 2016.

F3: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.